Cholangiocarcinoma: is it time for a revolution?

Expert Rev Gastroenterol Hepatol. 2021 May;15(5):467-470. doi: 10.1080/17474124.2021.1915766. Epub 2021 Apr 15.
No abstract available

Keywords: Biliary cancer; cholangiocarcinoma; immune checkpoints inhibitors; molecular targeted agents; perioperative therapy.

Publication types

  • Editorial

MeSH terms

  • Bile Duct Neoplasms / diagnosis
  • Bile Duct Neoplasms / mortality
  • Bile Duct Neoplasms / therapy*
  • Cholangiocarcinoma / diagnosis
  • Cholangiocarcinoma / mortality
  • Cholangiocarcinoma / therapy*
  • Humans
  • Prognosis